Airway inflammation in COPD: progress to precision medicine

Peter Lange, Bartolome Celli, Alvar Agustí, Gorm Boje Jensen, Miguel Divo, Rosa Faner, Stefano Guerra, Jacob Louis Marott, Fernando D. Martinez, Pablo Martinez-Camblor, Paula Meek, Caroline A. Owen, Hans Petersen, Victor Pinto-Plata, Peter Schnohr, Akshay Sood, Joan B. Soriano, Yohannes Tesfaigzi, Jørgen Vestbo, Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease The New England Journal of Medicine. ,vol. 373, pp. 111- 122 ,(2015) , 10.1056/NEJMOA1411532

Mona Bafadhel, Koirobi Haldar, Bethan Barker, Hemu Patel, Vijay Mistry, Michael Barer, Ian Pavord, Christopher Brightling, Airway bacteria measured by quantitative polymerase chain reaction and culture in patients with stable COPD: relationship with neutrophilic airway inflammation, exacerbation frequency, and lung function International Journal of Chronic Obstructive Pulmonary Disease. ,vol. 10, pp. 1075- 1083 ,(2015) , 10.2147/COPD.S80091

J F Elliott, V Paetkau, W Strober, G R Harriman, D Y Kunimoto, The role of IL-5 in IgA B cell differentiation. Journal of Immunology. ,vol. 140, pp. 3033- 3039 ,(1988)

Mona Bafadhel, Susan McKenna, Sarah Terry, Vijay Mistry, Carlene Reid, Pranabashis Haldar, Margaret McCormick, Koirobi Haldar, Tatiana Kebadze, Annelyse Duvoix, Kerstin Lindblad, Hemu Patel, Paul Rugman, Paul Dodson, Martin Jenkins, Michael Saunders, Paul Newbold, Ruth H. Green, Per Venge, David A. Lomas, Michael R. Barer, Sebastian L. Johnston, Ian D. Pavord, Christopher E. Brightling, Acute Exacerbations of Chronic Obstructive Pulmonary Disease American Journal of Respiratory and Critical Care Medicine. ,vol. 184, pp. 662- 671 ,(2011) , 10.1164/RCCM.201104-0597OC

M. Bafadhel, L. Davies, P. M. A. Calverley, S. D. Aaron, C. E. Brightling, I. D. Pavord, Blood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysis European Respiratory Journal. ,vol. 44, pp. 789- 791 ,(2014) , 10.1183/09031936.00062614

Steven Pascoe, Nicholas Locantore, Mark T Dransfield, Neil C Barnes, Ian D Pavord, Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials The Lancet Respiratory Medicine. ,vol. 3, pp. 435- 442 ,(2015) , 10.1016/S2213-2600(15)00106-X

G. M. Turino, R. M. Senior, B. D. Garg, S. Keller, M. M. Levi, I. Mandl, Serum Elastase Inhibitor Deficiency and agrl-Antitrypsin Deficiency in Patients with Obstructive Emphysema Science. ,vol. 165, pp. 709- 710 ,(1969) , 10.1126/SCIENCE.165.3894.709

A.M. Kirsten, K. Förster, E. Radeczky, A. Linnhoff, B. Balint, H. Watz, H. Wray, L. Salkeld, M. Cullberg, B. Larsson, The safety and tolerability of oral AZD5069, a selective CXCR2 antagonist, in patients with moderate-to-severe COPD. Pulmonary Pharmacology & Therapeutics. ,vol. 31, pp. 36- 41 ,(2015) , 10.1016/J.PUPT.2015.02.001

Stephen I. Rennard, David C. Dale, James F. Donohue, Frank Kanniess, Helgo Magnussen, E. Rand Sutherland, Henrik Watz, Susan Lu, Paul Stryszak, Elizabeth Rosenberg, Heribert Staudinger, CXCR2 Antagonist MK-7123. A Phase 2 Proof-of-Concept Trial for Chronic Obstructive Pulmonary Disease American Journal of Respiratory and Critical Care Medicine. ,vol. 191, pp. 1001- 1011 ,(2015) , 10.1164/RCCM.201405-0992OC

Stephen I. Rennard, Charles Fogarty, Steven Kelsen, William Long, Joe Ramsdell, James Allison, Donald Mahler, Constantine Saadeh, Thomas Siler, Phillip Snell, Phillip Korenblat, William Smith, Mitchell Kaye, Michael Mandel, Charles Andrews, Rachakonda Prabhu, James F. Donohue, Rosemary Watt, Kim Hung Lo, Rozsa Schlenker-Herceg, Elliot S. Barnathan, John Murray, The Safety and Efficacy of Infliximab in Moderate to Severe Chronic Obstructive Pulmonary Disease American Journal of Respiratory and Critical Care Medicine. ,vol. 175, pp. 926- 934 ,(2007) , 10.1164/RCCM.200607-995OC